Actively Recruiting
Autonomic Dysreflexia Clinical Characteristics Based on Urodynamic Filling Speed in People With Spinal Cord Injuries
Led by Pusan National University Yangsan Hospital · Updated on 2026-01-14
30
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research investigates autonomic dysreflexia (AD) in patients with chronic spinal cord injuries. The study aims to understand how the bladder injection rate during urodynamic tests affects the prevalence and characteristics of AD. Researchers also seek to determine whether bladder expansion or injection speed has a greater impact on AD, considering factors like patient age and bladder pressure. Participants will undergo urodynamic testing using saline solution at body temperature, administered at two different injection rates: 10 mL/min and 100 mL/min. The study compares these two speeds to observe differences in AD symptoms and bladder responses. The study is observational and focuses on measuring bladder volume and other related factors immediately after testing. During the study, participants will be monitored for bladder volume, bladder compliance, symptoms of AD, blood pressure, and heart rate right after the urodynamic test. These assessments help evaluate the severity and characteristics of AD related to the injection speeds. The total duration of participation and follow-up details are not specified, but safety monitoring related to blood pressure and urinary tract infections will be part of the evaluation.
CONDITIONS
Brief Title
Autonomic Dysreflexia in Spinal Cord Injuries: UDS Filling Speed Impact
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with chronic spinal cord injury at least 6 months after injury
- History of autonomic dysreflexia caused by bladder fullness during previous urodynamic tests
- Neurological damage level between C1 and T6 with AIS A or B classification
You will not qualify if you...
- Systolic blood pressure remains at or above 150 mmHg during the urodynamic test
- Hemodynamic instability preventing testing
- Presence of overt urinary tract infection preventing testing
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 day
Participants undergo urodynamic tests with two different saline injection speeds to assess autonomic dysreflexia characteristics.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, South Korea, 50612
Actively Recruiting
Research Team
S
Sungchul Huh, Ph.D
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here